Naltex (Naltrexone Hydrochloride)

Naltex, an opioid antagonist, is used in the treatment of substance‑dependence disorders.

• Opioid dependence: reduces cravings and blocks the euphoric effects of opioids, supporting abstinence.
• Alcohol dependence: diminishes the rewarding effects of alcohol, aiding in relapse prevention.
• Opioid use disorder: assists in maintenance therapy by antagonizing mu‑opioid receptors.

• Naltrexone acts as a competitive antagonist at opioid receptors, primarily the mu‑opioid subtype. By binding to these receptors without activating them, it blocks the effects of endogenous opioids and exogenous opioid substances, thereby reducing reinforcement, craving, and the risk of relapse in opioid and alcohol dependence.

Naltex may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Headache: transient cranial discomfort.
• Dizziness: occasional light‑headedness.
• Fatigue: feeling of reduced energy.
• Insomnia: difficulty initiating or maintaining sleep.
• Abdominal pain: mild discomfort in the stomach area.

Serious or Rare Side Effects

• Hepatotoxicity: elevated liver enzymes or liver injury.
• Severe hypotension: marked drop in blood pressure.
• Allergic reactions: rash, pruritus, or angioedema.
• Psychosis: rare emergence of hallucinations or delusional thoughts.

Before initiating Naltex, consider the following safety measures.

• Liver function: assess hepatic enzymes, especially in patients with known liver disease.
• Concomitant opioids: avoid abrupt discontinuation of opioid therapy to prevent withdrawal.
• Pregnancy: use only if the potential benefit justifies the potential risk to the fetus.
• Breastfeeding: evaluate risk versus benefit, as naltrexone may be excreted in milk.
• Renal impairment: monitor renal function in patients with severe kidney disease.

Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Naltex can interact with several medication classes; awareness of these interactions helps optimize safety.

Major Interactions (Avoid)

• Opioid analgesics: may precipitate acute withdrawal.
• Disulfiram: combined use can increase hepatotoxic risk.
• Certain antidepressants (e.g., MAO inhibitors): may enhance central nervous system effects.

Moderate Interactions (Monitor Closely)

• Benzodiazepines: concurrent use may increase sedation.
• Hepatotoxic drugs (e.g., isoniazid, methotrexate): monitor liver enzymes.
• Antidiabetic agents: naltrexone may affect glucose control, requiring periodic monitoring.